Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial
评估孕激素受体激动剂甲地孕酮联合来曲唑治疗早期雌激素受体阳性乳腺癌患者的疗效：一项机会窗口期、随机、IIb期PIONEER试验
期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-025-01087-x.
Rebecca A Burrell #,Sanjeev Kumar #,Elena Provenzano,Cleopatra Pike,Alimu Dayimu,Stuart A McIntosh,Vassilis Pitsinis,Polly King,Beatrix Elsberger,Sasi Govindarajulu,Lucy Satherley,Sirwan Hadad,Peter Schmid,Amit Agrawal,Bodiere Akpuluma,Steven Bell,John R Benson,Carlos Caldas,Danya Cheeseman,Igor Chernukhin,Parto Forouhi,Tulay Gulsen,Eleftheria Kleidi,Karen Pinilla,Wendi Qian,Jean E Abraham,Jason S Carroll,Richard D Baird
